(Total Views: 411)
Posted On: 12/27/2019 11:55:00 AM
Post# of 154115
Agreed,
Oncology will be the game-changer if it shows benefit. With HIV combo approved and Mono in pivotal trial we can expect single digits for SP; however, if Oncology works out we will be probably be BO for double digits.
Commercializing and developing Leronlimab into the next Keytruda will take lots of resources and effort.
BTW Merck should be watching closely (as anybody else). Maybe a Combo with Lero could provide a super-duper blockbuster drug.
Way to go … and I am very happy for the long-suffering fellow investors that have already seen the green.
Father Christmas delivered !!!
Oncology will be the game-changer if it shows benefit. With HIV combo approved and Mono in pivotal trial we can expect single digits for SP; however, if Oncology works out we will be probably be BO for double digits.
Commercializing and developing Leronlimab into the next Keytruda will take lots of resources and effort.
BTW Merck should be watching closely (as anybody else). Maybe a Combo with Lero could provide a super-duper blockbuster drug.
Way to go … and I am very happy for the long-suffering fellow investors that have already seen the green.
Father Christmas delivered !!!
(4)
(0)
